R. Inman

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

M. Dougados, B. Dijkmans, I. Olivieri, 2011, Annals of the rheumatic diseases.

OP0169 Sarilumab for the treatment of ankylosing spondylitis: Results of a phase 2, randomized. Double-blind, placebo-controlled, international study (align)

J. Braun, J. Sieper, S. Badalamenti, 2013 .

POS0306 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS REFRACTORY TO BIOLOGIC THERAPY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL

D. M. van der Heijde, A. Pangan, X. Bu, 2022, Annals of the Rheumatic Diseases.

Inflammatory and degenerative sacroiliac joint disease in a primary back pain cohort

C. Ammendolia, D. Salonen, R. Inman, 2010, Arthritis care & research.

Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in immunocompromised adult patients

A. Gingras, M. Silverberg, T. Watts, 2023, medRxiv.

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

M. Dougados, B. Dijkmans, I. Olivieri, 2009, Annals of the rheumatic diseases.

SAT0395 Similarities and differences between non-radiographic and radiographic axial spondyloarthritis in proof cohort

J. Sieper, S. Akar, D. Poddubnyy, 2017 .

DEMONSTRATES EQUIVALENCE IN PHARMACOKINETICS, SAFETY, AND EFFICACY OF CT-P13 AND INFLIXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS

J. Braun, J. Sieper, S. Badalamenti, 2022 .